Wenlock MC[au] - Search Results

Year	Number of Results
2002	1
2003	1
2005	1
2011	5
2013	1
2014	1
2015	2
2017	1
2018	1
2021	1
2022	0

1

Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of Filariasis.

McGillan P, Berry NG, Nixon GL, Leung SC, Webborn PJH, Wenlock MC, Kavanagh S, Cassidy A, Clare RH, Cook DA, Johnston KL, Ford L, Ward SA, Taylor MJ, Hong WD, O'Neill PM. McGillan P, et al. Among authors: wenlock mc. ACS Med Chem Lett. 2021 Aug 20;12(9):1421-1426. doi: 10.1021/acsmedchemlett.1c00216. eCollection 2021 Sep 9. ACS Med Chem Lett. 2021. PMID: 34527179 Free PMC article.

2

Oral drug suitability parameters.

Wenlock MC. Wenlock MC. Medchemcomm. 2018 Feb 5;9(3):460-470. doi: 10.1039/c7md00586e. eCollection 2018 Mar 1. Medchemcomm. 2018. PMID: 30108936 Free PMC article.

3

Designing safer oral drugs.

Wenlock MC. Wenlock MC. Medchemcomm. 2017 Jan 20;8(3):571-577. doi: 10.1039/c6md00706f. eCollection 2017 Mar 1. Medchemcomm. 2017. PMID: 30108773 Free PMC article.

4

Interpreting physicochemical experimental data sets.

Colclough N, Wenlock MC. Colclough N, et al. Among authors: wenlock mc. J Comput Aided Mol Des. 2015 Sep;29(9):779-94. doi: 10.1007/s10822-015-9850-7. Epub 2015 Jun 9. J Comput Aided Mol Des. 2015. PMID: 26054297

5

In silico physicochemical parameter predictions.

Wenlock MC, Barton P. Wenlock MC, et al. Mol Pharm. 2013 Apr 1;10(4):1224-35. doi: 10.1021/mp300537k. Epub 2013 Jan 24. Mol Pharm. 2013. PMID: 23305561

6

How experimental errors influence drug metabolism and pharmacokinetic QSAR/QSPR models.

Wenlock MC, Carlsson LA. Wenlock MC, et al. J Chem Inf Model. 2015 Jan 26;55(1):125-34. doi: 10.1021/ci500535s. Epub 2014 Dec 24. J Chem Inf Model. 2015. PMID: 25406036 Free article.

7

A method for measuring the lipophilicity of compounds in mixtures of 10.

Wenlock MC, Potter T, Barton P, Austin RP. Wenlock MC, et al. J Biomol Screen. 2011 Mar;16(3):348-55. doi: 10.1177/1087057110396372. Epub 2011 Feb 22. J Biomol Screen. 2011. PMID: 21343602

8

Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules.

Luker T, Alcaraz L, Chohan KK, Blomberg N, Brown DS, Butlin RJ, Elebring T, Griffin AM, Guile S, St-Gallay S, Swahn BM, Swallow S, Waring MJ, Wenlock MC, Leeson PD. Luker T, et al. Among authors: wenlock mc. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5673-9. doi: 10.1016/j.bmcl.2011.07.074. Epub 2011 Jul 27. Bioorg Med Chem Lett. 2011. PMID: 21852131

9

A highly automated assay for determining the aqueous equilibrium solubility of drug discovery compounds.

Wenlock MC, Austin RP, Potter T, Barton P. Wenlock MC, et al. J Lab Autom. 2011 Aug;16(4):276-84. doi: 10.1016/j.jala.2010.10.002. Epub 2011 Mar 26. J Lab Autom. 2011. PMID: 21764023

10

Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design.

Wenlock MC, Barton P, Luker T. Wenlock MC, et al. Bioorg Med Chem Lett. 2011 Jun 15;21(12):3550-6. doi: 10.1016/j.bmcl.2011.04.133. Epub 2011 May 5. Bioorg Med Chem Lett. 2011. PMID: 21601448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results